|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$69,528.60 |
3.18% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$65,769.45 |
3.01% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$55,135.05 |
2.52% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$53,148.22 |
2.43% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$49,158.56 |
2.25% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$48,742.26 |
2.23% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$48,496.41 |
2.22% |
| Waters Corporation |
WAT |
941848103 |
120 |
$48,064.80 |
2.20% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$47,482.60 |
2.17% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$47,524.10 |
2.17% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$47,174.72 |
2.16% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$46,985.20 |
2.15% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$46,608.23 |
2.13% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$46,273.15 |
2.12% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$46,334.24 |
2.12% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$46,039.65 |
2.11% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$45,533.49 |
2.08% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$45,242.15 |
2.07% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,121.99 |
2.02% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$43,947.04 |
2.01% |
| Steris Plc |
STE |
G8473T100 |
169 |
$43,945.07 |
2.01% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$43,617.00 |
2.00% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$43,099.20 |
1.97% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$42,772.68 |
1.96% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$42,909.27 |
1.96% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$42,686.16 |
1.95% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$41,938.09 |
1.92% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$41,929.58 |
1.92% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$41,689.88 |
1.91% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$41,490.55 |
1.90% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$40,876.22 |
1.87% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$40,250.09 |
1.84% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$39,997.89 |
1.83% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$39,936.51 |
1.83% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$39,889.75 |
1.83% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$39,833.70 |
1.82% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$39,522.42 |
1.81% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$39,276.44 |
1.80% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$38,812.05 |
1.78% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$38,461.78 |
1.76% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$38,368.36 |
1.76% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$37,701.34 |
1.73% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$37,701.60 |
1.73% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$37,830.20 |
1.73% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$37,553.74 |
1.72% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$37,339.35 |
1.71% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$37,382.45 |
1.71% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$36,630.93 |
1.68% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$35,767.33 |
1.64% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$32,455.27 |
1.49% |
| US Dollar |
$USD |
|
2,463 |
$2,463.43 |
0.11% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|